Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals
(AUPH)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Lupkynis
Voclosporin
2021-01-22
2023-2037
Lupus nephritis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Voclosporin
drug interactions
,
eye diseases
,
kidney diseases
,
focal segmental glomerulosclerosis
,
covid-19
,
lupus nephritis
,
nephritis
,
psoriasis
,
keratoconjunctivitis sicca
,
dry eye syndromes
,
kidney transplantation
,
keratoconjunctivitis
,
syndrome
Mycophenolate sodium
lupus nephritis
,
nephritis
Ademetionine
lupus nephritis
,
nephritis
Bevifimod
lupus nephritis
,
nephritis
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use